Literature DB >> 35726030

Secretome of senescent hepatoma cells modulate immune cell fate by macrophage polarization and neutrophil extracellular traps formation.

Bijoya Sen1,2, Savera Aggarwal1, Rhisita Nath1, Rashi Sehgal1, Ravinder Singh1, Khushboo Agrawal1, Ashwini Nagaraghatta Shashidhara3, Archana Rastogi3, Meenu Bajpai4, Viniyendra Pamecha5, Nirupma Trehanpati1, Gayatri Ramakrishna6.   

Abstract

Presence of dysfunctional senescent hepatocytes is a hallmark feature of liver cirrhosis which finally culminates in liver cancer. We now report the presence of senescent hepatocytes (p21 and p53 positive) in the vicinity of infiltrated immune cells in hepatocellular carcinoma tissue specimens by immunohistochemistry. Hence, we evaluated in vitro, the relevance of senescent hepatoma cells in altering the fate of monocytes and neutrophils by assaying for macrophage polarization and extracellular trap (NETs) formation, respectively. Premature senescence was induced in hepatoma cells (HepG2 and Huh7 cells) by treating cells with doxorubicin. Senescent hepatoma cells showed strong inflammatory phenotype with induced expression of cytokines (IL1β, IL6, IL8 and IL13) as evaluated by flow cytometry. The senescent secretome from hepatoma cells when incubated with healthy monocytes caused it to differentiate predominantly towards M2 fate (CD80low CD86low CD163high CD206high) when analysed by flow cytometry. This was corroborated by the finding in clinical samples where human hepatocellular carcinoma harbouring senescent hepatocytes showed presence of M2 macrophages, while M1 macrophages were predominant in non-tumorous region. Additionally, the senescent secretome from Huh7 cells enhanced the NETs formation, while HepG2 secretome had an inhibitory effect. In conclusion, the "pro-inflammatory" senescent secretome drives non-inflammatory type M2 macrophage polarization and modulated neutrophil traps which in turn can influence the tumor microenvironment.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  And inflammasome; Hepatocellular carcinoma (HCC); Macrophage polarization; Neutrophil extracellular traps (NETs); Senescence; Senescence-associated secretory phenotype (SASP)

Mesh:

Year:  2022        PMID: 35726030     DOI: 10.1007/s12032-022-01732-w

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  31 in total

Review 1.  From cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence.

Authors:  Gayatri Ramakrishna; Archana Rastogi; Nirupama Trehanpati; Bijoya Sen; Ritu Khosla; Shiv K Sarin
Journal:  Liver Cancer       Date:  2013-08       Impact factor: 11.740

Review 2.  Senescence in chronic liver disease: Is the future in aging?

Authors:  Aloysious D Aravinthan; Graeme J M Alexander
Journal:  J Hepatol       Date:  2016-05-28       Impact factor: 25.083

3.  Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse.

Authors:  Marco Demaria; Monique N O'Leary; Jianhui Chang; Lijian Shao; Su Liu; Fatouma Alimirah; Kristin Koenig; Catherine Le; Natalia Mitin; Allison M Deal; Shani Alston; Emmeline C Academia; Sumner Kilmarx; Alexis Valdovinos; Boshi Wang; Alain de Bruin; Brian K Kennedy; Simon Melov; Daohong Zhou; Norman E Sharpless; Hyman Muss; Judith Campisi
Journal:  Cancer Discov       Date:  2016-12-15       Impact factor: 39.397

Review 4.  The role of inflammation and liver cancer.

Authors:  Anupam Bishayee
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 5.  The immunology of hepatocellular carcinoma.

Authors:  Marc Ringelhan; Dominik Pfister; Tracy O'Connor; Eli Pikarsky; Mathias Heikenwalder
Journal:  Nat Immunol       Date:  2018-01-29       Impact factor: 25.606

6.  Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.

Authors:  Ruben Raphael Plentz; Young Nyun Park; André Lechel; Haeryoung Kim; Friederike Nellessen; Britta Heike Eva Langkopf; Ludwig Wilkens; Annarita Destro; Barbara Fiamengo; Michael Peter Manns; Massimo Roncalli; Karl Lenhard Rudolph
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

Review 7.  Telomere shortening and ageing.

Authors:  H Jiang; Z Ju; K L Rudolph
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

8.  Inflammation in background cirrhosis evokes malignant progression in HCC development from HCV-associated liver cirrhosis.

Authors:  Kazuo Tarao; Shinichi Ohkawa; Yohei Miyagi; Soichiro Morinaga; Kenji Ohshige; Naoto Yamamoto; Makoto Ueno; Satoshi Kobayashi; Ryo Kameda; Setsuo Tamai; Yoshiyasu Nakamura; Kaoru Miyakawa; Yoichi Kameda; Masahiko Okudaira
Journal:  Scand J Gastroenterol       Date:  2013-04-05       Impact factor: 2.423

9.  Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.

Authors:  Stefanie U Wiemann; Ande Satyanarayana; Martina Tsahuridu; Hans L Tillmann; Lars Zender; Juergen Klempnauer; Peer Flemming; Sonia Franco; Maria A Blasco; Michael P Manns; K Lenhard Rudolph
Journal:  FASEB J       Date:  2002-07       Impact factor: 5.191

10.  Senescent Hepatocytes in Decompensated Liver Show Reduced UPRMT and Its Key Player, CLPP, Attenuates Senescence In Vitro.

Authors:  Bijoya Sen; Archana Rastogi; Rhisita Nath; Saggere M Shasthry; Viniyendra Pamecha; Sonika Pandey; Kapuganti Jagadis Gupta; Shiv K Sarin; Nirupma Trehanpati; Gayatri Ramakrishna
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.